TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34059326

Group type: EXPERIMENTAL
Intervention: Transarterial radioembolization (TARE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 0
Study: 33046137

Group type: EXPERIMENTAL
Intervention: Genetically predicted telomere lengths based on SNPs (rs11125529 and rs412658)
Number of subjects: 735

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 735
Study: 36001314

Group type: EXPERIMENTAL
Intervention: Omission of sentinel lymph node biopsy (SLNB)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Interventions aimed at educating physicians, improving patient-physician communication, and facilitating preoperative multidisciplinary conversations
Number of subjects: 29
Study: 32144493

Group type: EXPERIMENTAL
Intervention: Spot urinary sodium excretion (high: UNa+ > 50 or low: ≤ 50 mEq/L) at 2 h from furosemide administration
Number of subjects: 80
Study: 35400072

Group type: EXPERIMENTAL
Intervention: Multi-component implementation strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 33065643

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT) consisting of radiation (50.4 Gy) with cisplatin and 5-fluorouracil
Number of subjects: 99

Group type: COMPARATOR
Intervention: Chemotherapy (CT) consisting of 2 cycles of docetaxel plus cisplatin and 5-fluorouracil (DCF)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: R0 resection rate
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Histological nodal status
Number of subjects: 99
Study: 32135413

Group type: EXPERIMENTAL
Intervention: Pegbovigrastim (IMR) treatment (2.7 mL of Imrestor)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control (CON) treatment (2.7 mL of 0.9% saline)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Pegbovigrastim (IMR) treatment
Number of subjects: 270

Group type: COMPARATOR
Intervention: Control (CON) treatment
Number of subjects: 270
Study: 33471429

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with conventional therapy (systemic antibiotics and trazodone)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham therapy (laser/LEDs off) with conventional therapy (systemic antibiotics and trazodone)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham therapy (laser/LEDs off)
Number of subjects: 13
Study: 35279934

Group type: EXPERIMENTAL
Intervention: Promoting Resilience in Nurses (PRiN) programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33635767

Group type: EXPERIMENTAL
Intervention: Relationship continuity (PCP ordered the study DXA)
Number of subjects: 1996
Study: 32758147

Group type: EXPERIMENTAL
Intervention: PECAN intervention (complex intervention to enable nurses to promote participation)
Number of subjects: 7
Study: 35606677

Group type: EXPERIMENTAL
Intervention: Modified Otago exercise program (OEP)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study: 34057130

Group type: EXPERIMENTAL
Intervention: Small-amplitude FLEXI-BAR exercise (FBE)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Large-amplitude FLEXI-BAR exercise (FBE)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Zero-amplitude FLEXI-BAR exercise (FBE)
Number of subjects: 36
Study: 33045430

Group type: EXPERIMENTAL
Intervention: Hybrid Convergent procedure (combined epicardial/endocardial ablation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endocardial-only approach
Number of subjects: 0
Study: 33370348

Group type: EXPERIMENTAL
Intervention: Cysteamine 450mg twice daily
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 32825677

Group type: EXPERIMENTAL
Intervention: Meditative (Hatha style) yoga
Number of subjects: 13

Group type: COMPARATOR
Intervention: Power (Vinyasa style) yoga
Number of subjects: 13
Study: 34216939

Group type: EXPERIMENTAL
Intervention: Fetal Scalp Stimulation (FSS) performed for 15 seconds before each FBS.
Number of subjects: 148

Group type: COMPARATOR
Intervention: Fetal Blood Sampling (FBS) considered as the gold standard for assessing fetal wellbeing.
Number of subjects: 148
Study: 35581609

Group type: EXPERIMENTAL
Intervention: Web-based support group intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 160
Study: 33412401

Group type: EXPERIMENTAL
Intervention: Tron FX 4/20 mm
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tron FX 2/15 mm
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Tron FX (both sizes)
Number of subjects: 50
Study: 32253227

Group type: EXPERIMENTAL
Intervention: Lumbopelvic postural feedback device
Number of subjects: 130

Group type: COMPARATOR
Intervention: Sham group (SG)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Comparison between feedback group and SG
Number of subjects: 130
Study: 36394954

Group type: EXPERIMENTAL
Intervention: Patient’s Own Choice (POC) group, where 70% chose to receive results by telephone.
Number of subjects: 406

Group type: COMPARATOR
Intervention: RCT group (randomly assigned to delivery method).
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Telephone subgroup within POC group.
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: In-person subgroup within POC group.
Number of subjects: 406
Study: 32019982

Group type: EXPERIMENTAL
Intervention: Knotless anchor (KA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Suture-button (SB)
Number of subjects: 20
Study: 35099050

Group type: EXPERIMENTAL
Intervention: AioCare® portable spirometer
Number of subjects: 62
Study: 34088727

Group type: EXPERIMENTAL
Intervention: Bronchial artery embolisation (BAE) associated with medical therapy
Number of subjects: 72

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 72
Study: 33055588

Group type: EXPERIMENTAL
Intervention: Vaccine group (VG) - 1 mg each of three epitope peptides injected postoperatively 10 times weekly followed by 10 times biweekly.
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group (CG) - No specific intervention details provided.
Number of subjects: 63
Study: 32052432

Group type: EXPERIMENTAL
Intervention: Short-term healing (8 to 10 weeks)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Long-term healing (18 to 20 weeks)
Number of subjects: 44
Study: 33785209

Group type: EXPERIMENTAL
Intervention: SV‐VATS
Number of subjects: 335

Group type: COMPARATOR
Intervention: MV‐VATS
Number of subjects: 335
Study: 32030619

Group type: EXPERIMENTAL
Intervention: Single dose of a combined oral contraceptive containing 0.03 mg ethinylestradiol/0.15 mg levonorgestrel
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (BMI-matched women with no previous history of Roux‐en‐Y gastric bypass surgery)
Number of subjects: 30
Study: 35851031

Group type: EXPERIMENTAL
Intervention: Oral metformin hydrochloride 500 mg tablets, taken three times a day for 4 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Matched placebo, taken three times a day for 4 months
Number of subjects: 80
Study: 34092822

Group type: EXPERIMENTAL
Intervention: SPN-812 400-mg/day
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: SPN-812 600-mg/day
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study: 32458531

Group type: EXPERIMENTAL
Intervention: Star Excursion Balance Test (SEBT)
Number of subjects: 29
Study: 33241985

Group type: EXPERIMENTAL
Intervention: Culturally modified Organ Donation Model (ODM)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Descriptive norms
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Non-cognitive beliefs
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Anticipated regret
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Subjective norms
Number of subjects: 600
Study: 33676794

Group type: EXPERIMENTAL
Intervention: One cross-link insertion (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Two cross-links insertion (Group C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No cross-link insertion (Group A)
Number of subjects: 60
Study: 34886700

Group type: EXPERIMENTAL
Intervention: 5 sessions of acupuncture (group A)
Number of subjects: 156

Group type: COMPARATOR
Intervention: 10 sessions of acupuncture (group B)
Number of subjects: 156
Study: 34518679

Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (4.5×10^5, 9.0×10^5, or 1.8×10^6 doses)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (1.8×10^6 dose)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (9.0×10^5 dose)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: PfSPZ Vaccine (all doses)
Number of subjects: 336
Study: 35254888

Group type: EXPERIMENTAL
Intervention: dd-MVAC (dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin)
Number of subjects: 500

Group type: COMPARATOR
Intervention: GC (gemcitabine and cisplatin)
Number of subjects: 500
Study: 32556437

Group type: EXPERIMENTAL
Intervention: Measured resection technique
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Gap balancing technique
Number of subjects: 100
Study: 32461289

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum preconditioning (PP) consisting of three cycles of 5 min insufflation and 5 min desufflation before LPN
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham operation (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum preconditioning (PP)
Number of subjects: 0
Study: 34080718

Group type: EXPERIMENTAL
Intervention: Vonoprazan-containing quadruple therapy (20 mg vonoprazan, 220 mg bismuth, 500 mg clarithromycin, 1000 mg amoxicillin twice daily for 14 days)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Lansoprazole-containing quadruple therapy (30 mg lansoprazole, 220 mg bismuth, 500 mg clarithromycin, 1000 mg amoxicillin twice daily for 14 days)
Number of subjects: 30
Study: 33454768

Group type: EXPERIMENTAL
Intervention: Early anti-androgen treatment
Number of subjects: 15106

Group type: EXPERIMENTAL
Intervention: Normo-androgenic women with PCOS
Number of subjects: 15106

Group type: EXPERIMENTAL
Intervention: Hyperandrogenic women with PCOS
Number of subjects: 15106

Group type: EXPERIMENTAL
Intervention: Severely hyperandrogenic women with PCOS
Number of subjects: 15106

Group type: EXPERIMENTAL
Intervention: Mildly hyperandrogenic women with PCOS
Number of subjects: 15106

Group type: COMPARATOR
Intervention: Late anti-androgen treatment
Number of subjects: 15106
Study: 36203077

Group type: EXPERIMENTAL
Intervention: Lidocaine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (Normal Saline)
Number of subjects: 120
Study: 33260471

Group type: EXPERIMENTAL
Intervention: Regular physical activity counseling by trained healthcare providers
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (routine pregnancy care without additional counseling)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Regular physical activity counseling
Number of subjects: 96
Study: 35368965

Group type: EXPERIMENTAL
Intervention: Biyuan Tongqiao granules combined with nasal irrigation with normal saline
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nasal irrigation with normal saline
Number of subjects: 90
Study: 33095658

Group type: EXPERIMENTAL
Intervention: Microcurrent therapy (active device) for 3 hours per day for 4 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (control group) for 3 hours per day for 4 weeks
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Microcurrent therapy
Number of subjects: 52
Study: 32349260

Group type: EXPERIMENTAL
Intervention: Facilitated behavioral intervention based on the extended theory of planned behavior (TPB)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 51
Study: 36349666

Group type: EXPERIMENTAL
Intervention: Surgical masks worn by hearing aid users
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Surgical masks worn by hearing aid users with lipreading
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (normal hearing)
Number of subjects: 55
Study: 35361646

Group type: EXPERIMENTAL
Intervention: Probiotic yoghurt (300 g/day containing 106 CFU/g Lactobacillus acidophilus and Bifidobacterium lactis)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Plain yoghurt (300 g/day)
Number of subjects: 60
Study: 32050044

Group type: EXPERIMENTAL
Intervention: Recovery Record (smartphone application)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Traditional paper records
Number of subjects: 90
Study: 33431716

Group type: EXPERIMENTAL
Intervention: Statin therapy (pitavastatin)
Number of subjects: 9221
Study: 34693434

Group type: COMPARATOR
Intervention: 0 g of orthodontic force (Group A)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 75 g of orthodontic force (Group B)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 150 g of orthodontic force (Group C)
Number of subjects: 74
Study: 32877509

Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: COMPARATOR
Intervention: Control
Number of subjects: 132
Study: 34716979

Group type: COMPARATOR
Intervention: Chemotherapy alone (pegylated liposomal doxorubicin [40 or 50 mg/m2], topotecan [1.25 mg/m2], paclitaxel [80 mg/m2], or gemcitabine [1000 mg/m2])
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Chemotherapy + bevacizumab (15 mg/m2)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Chemotherapy + bevacizumab
Number of subjects: 103
Study: 33076866

Group type: EXPERIMENTAL
Intervention: Genotypic resistance testing (GRT) to inform onward treatment
Number of subjects: 276

Group type: COMPARATOR
Intervention: Standard of care (3 sessions of enhanced adherence counselling, follow-up VL test, continuation of same regimen upon viral resuppression or empiric selection of a new regimen upon sustained elevated viremia)
Number of subjects: 276
Study: 32719399

Group type: EXPERIMENTAL
Intervention: Gene expression signature MammaPrint
Number of subjects: 6693

Group type: EXPERIMENTAL
Intervention: Technical variation removal
Number of subjects: 6693
Study: 35904580

Group type: EXPERIMENTAL
Intervention: Caffeine (200 mg, oral)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 56
Study: 34551744

Group type: EXPERIMENTAL
Intervention: Supplementary nutrition education and dietary counselling
Number of subjects: 257

Group type: COMPARATOR
Intervention: Routine ANC services (Control)
Number of subjects: 257
Study: 36257290

Group type: EXPERIMENTAL
Intervention: Tutorial from trained peer teachers (TPTs)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Standard ultrasound (US) tutorial from various resident doctors
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Early phase OSCE results
Number of subjects: 168
Study: 32307624

Group type: EXPERIMENTAL
Intervention: Full-dose ketamine (0.5 mg kg‐1 initial bolus, 10 mcg kg‐1 min‐1 infusion)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Half-dose ketamine (0.25 mg kg‐1 bolus, 5 mcg kg‐1 min‐1 infusion)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (no ketamine)
Number of subjects: 30
Study: 35861777

Group type: EXPERIMENTAL
Intervention: Total knee replacement surgery
Number of subjects: 272
Study: 34971074

Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide (HP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: 37% carbamide peroxide (CP)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: 38% hydrogen peroxide with sonic activation (HPS)
Number of subjects: 56

Group type: COMPARATOR
Intervention: 37% carbamide peroxide with sonic activation (CPS)
Number of subjects: 56
Study: 33356517

Group type: EXPERIMENTAL
Intervention: Early patient‐directed rehabilitation
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard rehabilitation including sling immobilisation for four weeks
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Early mobilisation
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Trial processes
Number of subjects: 19
Study: 35488019

Group type: EXPERIMENTAL
Intervention: High skeletal muscle mass (SM-M Z-score)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: High visceral adipose tissue radiation attenuation (VAT-RA Z-score)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: High subcutaneous adipose tissue radiation attenuation (SAT-RA Z-score)
Number of subjects: 112
Study: 33880701

Group type: EXPERIMENTAL
Intervention: Recovering Together (RT) intervention for survivors
Number of subjects: 116

Group type: COMPARATOR
Intervention: Attention placebo educational control
Number of subjects: 116
Study: 35220182

Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg every three weeks for one year)
Number of subjects: 1019

Group type: EXPERIMENTAL
Intervention: β-blockers (oral administration within 30 days of randomisation)
Number of subjects: 1019

Group type: EXPERIMENTAL
Intervention: Pembrolizumab with β-blockers
Number of subjects: 1019

Group type: COMPARATOR
Intervention: Placebo with β-blockers
Number of subjects: 1019

Group type: EXPERIMENTAL
Intervention: Pembrolizumab without β-blockers
Number of subjects: 1019
Study: 32985064

Group type: EXPERIMENTAL
Intervention: Low-dose THC (5 or 10 mg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High-dose THC (20 or 25 mg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo cannabis
Number of subjects: 50
Study: 33220252

Group type: EXPERIMENTAL
Intervention: Anti-H pylori therapy
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: H pylori-negative status
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Individuals with IM at baseline
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Incomplete-type IM at baseline
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Corpus IM vs antrum-restricted IM
Number of subjects: 800
Study: 36423863

Group type: EXPERIMENTAL
Intervention: Referral to primary care with enhanced care coordination
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Online self-administered cognitive behavioral therapy with guided peer support
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Therapist-administered cognitive behavior therapy
Number of subjects: 375
Study: 36226241

Group type: EXPERIMENTAL
Intervention: Nursing based on health belief guidance
Number of subjects: 126

Group type: COMPARATOR
Intervention: Mode group (knowledge, belief, and practice)
Number of subjects: 126
Study: 32471657

Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises (4 times/day) and protein-rich oral nutritional supplement (2 bottles/day providing 600 kcal and 36 g protein) for 12 weeks
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Sit-to-stand exercises and protein-rich oral nutritional supplement with high adherence (at least 40% compliance)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 120
Study: 35444249

Group type: EXPERIMENTAL
Intervention: Air‐circulating green walls
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (no green walls)
Number of subjects: 2
Study: 34132776

Group type: EXPERIMENTAL
Intervention: Pneumatic Retinopexy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pars Plana Vitrectomy
Number of subjects: 0
Study: 34922038

Group type: EXPERIMENTAL
Intervention: Ranibizumab administered monthly
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Ranibizumab administered pro re nata
Number of subjects: 1094

Group type: EXPERIMENTAL
Intervention: Ranibizumab (both regimens)
Number of subjects: 1094
Study: 32697476

Group type: EXPERIMENTAL
Intervention: Sunflower Seed Oil (SSO)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Almond Oil (AO)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study: 33470139

Group type: EXPERIMENTAL
Intervention: Cenobamate (CNB) as adjunct therapy
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1300
Study: 33812743

Group type: EXPERIMENTAL
Intervention: 13-valent pneumococcal conjugate vaccine (PCV13) before transplantation and a second dose 6 months after transplantation
Number of subjects: 47

Group type: COMPARATOR
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPV23) before transplantation
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Second dose of 13-valent pneumococcal conjugate vaccine (PCV13)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 47
Study: 33276919

Group type: EXPERIMENTAL
Intervention: MIN1 × (Calmin at 1 × concentration)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: MIN2 × (Calmin at 2 × concentration)
Number of subjects: 9

Group type: COMPARATOR
Intervention: CON (no added Calmin)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Overall effect
Number of subjects: 9
Study: 34650018

Group type: EXPERIMENTAL
Intervention: 6.5% proanthocyanidin (PAC)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 0.02% phytosphingosine (PHS)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control (no pretreatment)
Number of subjects: 33
Study: 35410437

Group type: EXPERIMENTAL
Intervention: Advanced dementia care management for 6 months, carried out by specialized nurses.
Number of subjects: 465

Group type: COMPARATOR
Intervention: Routine care for 6 months (waiting-control group).
Number of subjects: 465
Study: 33821897

Group type: EXPERIMENTAL
Intervention: Antimicrobial use
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Antimicrobial use in residents admitted within 30 days
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Antimicrobial use in residents with central venous catheters
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Antimicrobial use in residents with indwelling urinary catheters
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Antimicrobial use for active infections
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Antimicrobial use for urinary tract infections
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Antimicrobial use for medical prophylaxis
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Antimicrobial use for urinary tract prophylaxis
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Fluoroquinolones
Number of subjects: 15276

Group type: EXPERIMENTAL
Intervention: Broad-spectrum antibiotics
Number of subjects: 15276